LENSAR Profit Margin

LENSAR (LNSR) currently reports a profit margin of 57.57% as of June 2026. That compares with -84.49% in the prior-year period — up 168.1% year over year. That is above the Healthcare sector average of 13.76%. Use the charts on this page to explore LENSAR's profit margin history and peer comparisons.

LENSAR's profit margin increased from -84.49% to 57.57% — a 168.1% year-over-year increase (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

LENSAR's profit margin of 57.57% is higher than the Healthcare sector average of 13.76%. That is roughly 318.4% above the sector mean. A reading higher peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

There is no universal 'good' profit margin, but LENSAR's current 57.57% should be judged against Healthcare norms (sector average: 13.76%) and against LNSR's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.

Start with the current profit margin of 57.57%, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is 13.76%. From there, open related valuation or income-statement pages for LENSAR, and consider following LNSR for alerts when major investors trade the stock.